These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 661604)

  • 1. Statistical problems in monitoring adverse drug reactions.
    Moussa MA
    Methods Inf Med; 1978 Apr; 17(2):106-12. PubMed ID: 661604
    [No Abstract]   [Full Text] [Related]  

  • 2. Active Monitoring of Adverse Drug Reactions with Neural Network Technology.
    Wu T; Gao CC; Lin JS; Zha JL
    Chin Med J (Engl); 2017 Jun; 130(12):1498-1501. PubMed ID: 28584215
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse drug reactions: reducing the burden of treatment.
    Jordan S
    Nurs Stand; 2007 May 2-8; 21(34):35-41. PubMed ID: 17518073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions: a pharmacist-based monitoring system.
    Gardner P; Watson LJ
    Clin Pharmacol Ther; 1970; 11(6):802-7. PubMed ID: 5481567
    [No Abstract]   [Full Text] [Related]  

  • 5. Statisical logic in the monitoring of reactions to therapeutic drugs.
    Finney DJ
    Methods Inf Med; 1971 Oct; 10(4):237-45. PubMed ID: 5124593
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of therapeutic drug monitoring.
    Vozeh S
    Clin Pharmacokinet; 1987 Sep; 13(3):131-40. PubMed ID: 3117472
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System.
    Friedman GD; Collen MF; Harris LE; Van Brunt EE; Davis LS
    JAMA; 1971 Aug; 217(5):567-72. PubMed ID: 5109088
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring the adverse reactions to drugs and the discipline of therapeutic auditing.
    Wade OL
    Q J Med; 1971 Oct; 40(160):570-1. PubMed ID: 5157414
    [No Abstract]   [Full Text] [Related]  

  • 9. Toward the operational identification of adverse drug reactions.
    Karch FE; Lasagna L
    Clin Pharmacol Ther; 1977 Mar; 21(3):247-54. PubMed ID: 837643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical recognition of trends in health monitoring systems.
    Brockett PL; Kemperman JH
    Methods Inf Med; 1980 Apr; 19(2):106-12. PubMed ID: 7382832
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse reactions to drugs.
    Kimbel KH
    Lancet; 1977 Feb; 1(8006):308. PubMed ID: 64832
    [No Abstract]   [Full Text] [Related]  

  • 12. [Active prospective monitoring of pharmacotherapy safety in outpatients: practical value].
    Nazimkin KE; Kukes VG
    Antibiot Khimioter; 2008; 53(11-12):39-43. PubMed ID: 19441657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital information systems and the quality of therapeutics.
    Blaschke TF
    Methods Inf Med; 1990 Jul; 29(3):163-6. PubMed ID: 2215257
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)].
    Hoigné R; Sollberger J; Zoppi M; Müller U; Hess T; Fritschy D; Stocker F; Maibach R
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1854-7. PubMed ID: 6515386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An algorithm for monitoring and managing drug hepatotoxicity.
    Hofmann AF; Thistle JL
    Gastroenterology; 1974 Aug; 67(2):309-13. PubMed ID: 4847711
    [No Abstract]   [Full Text] [Related]  

  • 16. Causes of severe morbidity/mortality cases.
    de Julien LF
    CDA J; 1983 Feb; 11(2):45-8. PubMed ID: 6572112
    [No Abstract]   [Full Text] [Related]  

  • 17. Once is not enough.
    Gross F
    Eur J Clin Pharmacol; 1977; 11(5):323-4. PubMed ID: 880970
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and evaluation of adverse drug reactions.
    Miller RR; Shapiro S
    JAMA; 1972 May; 220(7):1011. PubMed ID: 5067442
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring adverse reactions to drugs: toward a therapeutic audit.
    Wade OL; Beeley L
    Int J Health Serv; 1974; 4(1):109-23. PubMed ID: 4597989
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear cardiology-Part I.
    Boade WA
    S D J Med; 1982 Feb; 35(2):23-7. PubMed ID: 6953587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.